Nuvation Bio
NUVB
NUVB
161 hedge funds and large institutions have $365M invested in Nuvation Bio in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 52 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
31% less capital invested
Capital invested by funds: $526M → $365M (-$161M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
99% less call options, than puts
Call options by funds: $10K | Put options by funds: $899K
Holders
161
Holding in Top 10
3
Calls
$10K
Puts
$899K
Top Buyers
| 1 | +$9.35M | |
| 2 | +$5.95M | |
| 3 | +$4.31M | |
| 4 |
Millennium Management
New York
|
+$2.28M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.23M |
Top Sellers
| 1 | -$2.29M | |
| 2 | -$1.78M | |
| 3 | -$1.77M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.72M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.21M |
